Alpha Teknova (TKNO) Competitors

Alpha Teknova (NASDAQ:TKNO) and Amphastar Pharmaceuticals (NASDAQ:AMPH) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk.

Do analysts prefer TKNO or AMPH?

Alpha Teknova presently has a consensus target price of $8.50, indicating a potential upside of 62.84%. Amphastar Pharmaceuticals has a consensus target price of $32.33, indicating a potential upside of 39.52%. Given Alpha Teknova's stronger consensus rating and higher probable upside, research analysts clearly believe Alpha Teknova is more favorable than Amphastar Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Teknova	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Amphastar Pharmaceuticals	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.25

Is TKNO or AMPH more profitable?

Amphastar Pharmaceuticals has a net margin of 19.38% compared to Alpha Teknova's net margin of -60.90%. Amphastar Pharmaceuticals' return on equity of 22.20% beat Alpha Teknova's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Teknova	-60.90%	-28.48%	-19.73%
Amphastar Pharmaceuticals	19.38%	22.20%	10.40%

Which has more risk & volatility, TKNO or AMPH?

Alpha Teknova has a beta of 0.33, indicating that its share price is 67% less volatile than the S&P 500. Comparatively, Amphastar Pharmaceuticals has a beta of 0.72, indicating that its share price is 28% less volatile than the S&P 500.

Which has stronger valuation and earnings, TKNO or AMPH?

Amphastar Pharmaceuticals has higher revenue and earnings than Alpha Teknova. Alpha Teknova is trading at a lower price-to-earnings ratio than Amphastar Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Teknova	$37.74M	7.39	-$26.75M	-$0.48	-10.88
Amphastar Pharmaceuticals	$731.97M	1.49	$159.52M	$2.76	8.40

Does the media refer more to TKNO or AMPH?

In the previous week, Amphastar Pharmaceuticals had 3 more articles in the media than Alpha Teknova. MarketBeat recorded 6 mentions for Amphastar Pharmaceuticals and 3 mentions for Alpha Teknova. Alpha Teknova's average media sentiment score of 0.63 beat Amphastar Pharmaceuticals' score of 0.38 indicating that Alpha Teknova is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alpha Teknova	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Amphastar Pharmaceuticals	2 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do insiders & institutionals have more ownership in TKNO or AMPH?

13.8% of Alpha Teknova shares are held by institutional investors. Comparatively, 65.1% of Amphastar Pharmaceuticals shares are held by institutional investors. 12.5% of Alpha Teknova shares are held by company insiders. Comparatively, 27.5% of Amphastar Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Amphastar Pharmaceuticals beats Alpha Teknova on 11 of the 16 factors compared between the two stocks.